The advent of **liquid biopsy** represents a paradigm shift in oncology, moving away from invasive and often risky surgical tissue biopsies toward a simple blood draw. This revolutionary non-invasive technique analyzes circulating biomarkers—such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and extracellular vesicles (EVs)—present in bodily fluids. The primary...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt